| Product Code: ETC12836057 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Infectious Vaccines Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Infectious Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Infectious Vaccines Market - Industry Life Cycle |
3.4 Mexico Infectious Vaccines Market - Porter's Five Forces |
3.5 Mexico Infectious Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Infectious Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Mexico Infectious Vaccines Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
3.8 Mexico Infectious Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Infectious Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in Mexico |
4.2.2 Government initiatives to improve vaccination coverage |
4.2.3 Growing prevalence of infectious diseases in Mexico |
4.3 Market Restraints |
4.3.1 High cost associated with vaccine development and distribution |
4.3.2 Limited access to healthcare facilities in rural areas of Mexico |
5 Mexico Infectious Vaccines Market Trends |
6 Mexico Infectious Vaccines Market, By Types |
6.1 Mexico Infectious Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Infectious Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Mexico Infectious Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021 - 2031F |
6.1.4 Mexico Infectious Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021 - 2031F |
6.1.5 Mexico Infectious Vaccines Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2 Mexico Infectious Vaccines Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Mexico Infectious Vaccines Market Revenues & Volume, By COVID-19, 2021 - 2031F |
6.2.3 Mexico Infectious Vaccines Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.4 Mexico Infectious Vaccines Market Revenues & Volume, By Hepatitis, 2021 - 2031F |
6.3 Mexico Infectious Vaccines Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Mexico Infectious Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Mexico Infectious Vaccines Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.4 Mexico Infectious Vaccines Market Revenues & Volume, By Government Immunization Programs, 2021 - 2031F |
6.4 Mexico Infectious Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Mexico Infectious Vaccines Market Revenues & Volume, By Public Health Agencies, 2021 - 2031F |
6.4.3 Mexico Infectious Vaccines Market Revenues & Volume, By Private Clinics, 2021 - 2031F |
7 Mexico Infectious Vaccines Market Import-Export Trade Statistics |
7.1 Mexico Infectious Vaccines Market Export to Major Countries |
7.2 Mexico Infectious Vaccines Market Imports from Major Countries |
8 Mexico Infectious Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rate among target population |
8.2 Number of government-funded vaccination programs implemented |
8.3 Research and development investments in new infectious vaccines |
9 Mexico Infectious Vaccines Market - Opportunity Assessment |
9.1 Mexico Infectious Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Infectious Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Mexico Infectious Vaccines Market Opportunity Assessment, By End-Use, 2021 & 2031F |
9.4 Mexico Infectious Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Infectious Vaccines Market - Competitive Landscape |
10.1 Mexico Infectious Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Mexico Infectious Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here